Literature DB >> 24029412

Cognitive patterns in relation to biomarkers of cerebrovascular disease and vascular risk factors.

Júlia Miralbell1, Elena López-Cancio, Jorge López-Oloriz, Juan Francisco Arenillas, Maite Barrios, Juan José Soriano-Raya, Amparo Galán, Cynthia Cáceres, Maite Alzamora, Guillem Pera, Pere Toran, Antoni Dávalos, Maria Mataró.   

Abstract

BACKGROUND: Risk factors for vascular cognitive impairment (VCI) are the same as traditional risk factors for cerebrovascular disease (CVD). Early identification of subjects at higher risk of VCI is important for the development of effective preventive strategies. In addition to traditional vascular risk factors (VRF), circulating biomarkers have emerged as potential tools for early diagnoses, as they could provide in vivo measures of the underlying pathophysiology. While VRF have been consistently linked to a VCI profile (i.e., deficits in executive functions and processing speed), the cognitive correlates of CVD biomarkers remain unclear. In this population-based study, the aim was to study and compare cognitive patterns in relation to VRF and circulating biomarkers of CVD.
METHODS: The Barcelona-AsIA Neuropsychology Study included 747 subjects older than 50, without a prior history of stroke or coronary disease and with a moderate to high vascular risk (mean age, 66 years; 34.1% women). Three cognitive domains were derived from factoral analysis: visuospatial skills/speed, verbal memory and verbal fluency. Multiple linear regression was used to assess relationships between cognitive performance (multiple domains) and a panel of circulating biomarkers, including indicators of inflammation, C-reactive protein (CRP) and resistin, endothelial dysfunction, asymmetric dimethylarginine (ADMA), thrombosis, plasminogen activator inhibitor 1 (PAI-1), as well as traditional VRF, metabolic syndrome and insulin resistance (homeostatic model assessment for insulin resistance index). Analyses were adjusted for age, gender, years of education and depressive symptoms.
RESULTS: Traditional VRF were related to lower performance in verbal fluency, insulin resistance accounted for lower performance in visuospatial skills/speed and the metabolic syndrome predicted lower performance in both cognitive domains. From the biomarkers of CVD, CRP was negatively related to verbal fluency performance and increasing ADMA levels were associated with lower performance in verbal memory. Resistin and PAI-1 did not relate to cognitive function performance.
CONCLUSION: Vascular risk factors, and markers of inflammation and endothelial dysfunction predicted lower performance in several cognitive domains. Specifically, cognitive functions associated with CRP are typically affected in VCI and overlap those related to VRF. ADMA indicated a dissociation in the cognitive profile involving verbal memory. These findings suggest that inflammation and endothelial dysfunction might play a role in the predementia cognitive impairment stages.
Copyright © 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24029412     DOI: 10.1159/000352059

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN: 1015-9770            Impact factor:   2.762


  16 in total

1.  Pharmacologically-induced neurovascular uncoupling is associated with cognitive impairment in mice.

Authors:  Stefano Tarantini; Peter Hertelendy; Zsuzsanna Tucsek; M Noa Valcarcel-Ares; Nataliya Smith; Akos Menyhart; Eszter Farkas; Erik L Hodges; Rheal Towner; Ferenc Deak; William E Sonntag; Anna Csiszar; Zoltan Ungvari; Peter Toth
Journal:  J Cereb Blood Flow Metab       Date:  2015-07-15       Impact factor: 6.200

2.  Suppression of TLR4/NF-κB Signaling Pathway Improves Cerebral Ischemia-Reperfusion Injury in Rats.

Authors:  Hang Zhao; Zhuo Chen; Li-Juan Xie; Gui-Feng Liu
Journal:  Mol Neurobiol       Date:  2017-06-17       Impact factor: 5.590

Review 3.  Neurobiological Highlights of Cognitive Impairment in Psychiatric Disorders.

Authors:  Anna Morozova; Yana Zorkina; Olga Abramova; Olga Pavlova; Konstantin Pavlov; Kristina Soloveva; Maria Volkova; Polina Alekseeva; Alisa Andryshchenko; Georgiy Kostyuk; Olga Gurina; Vladimir Chekhonin
Journal:  Int J Mol Sci       Date:  2022-01-22       Impact factor: 5.923

4.  Pharmacologically induced impairment of neurovascular coupling responses alters gait coordination in mice.

Authors:  Stefano Tarantini; Andriy Yabluchanksiy; Gábor A Fülöp; Peter Hertelendy; M Noa Valcarcel-Ares; Tamas Kiss; Jonathan M Bagwell; Daniel O'Connor; Eszter Farkas; Farzaneh Sorond; Anna Csiszar; Zoltan Ungvari
Journal:  Geroscience       Date:  2017-12-14       Impact factor: 7.713

5.  Cognitive Correlates of MRI-defined Cerebral Vascular Injury and Atrophy in Elderly American Indians: The Strong Heart Study.

Authors:  Astrid Suchy-Dicey; Dean Shibata; Brenna Cholerton; Lonnie Nelson; Darren Calhoun; Tauqeer Ali; Thomas J Montine; W T Longstreth; Dedra Buchwald; Steven P Verney
Journal:  J Int Neuropsychol Soc       Date:  2019-12-03       Impact factor: 2.892

6.  Hypertension and Hypercholesterolemia Modify Dementia Risk in Relation to APOEɛ4 Status.

Authors:  Jagan A Pillai; Lei Kou; James Bena; Lisa Penn; James B Leverenz
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

7.  Obesity-induced cognitive impairment in older adults: a microvascular perspective.

Authors:  Priya Balasubramanian; Tamas Kiss; Stefano Tarantini; Ádám Nyúl-Tóth; Chetan Ahire; Andriy Yabluchanskiy; Tamas Csipo; Agnes Lipecz; Adam Tabak; Adam Institoris; Anna Csiszar; Zoltan Ungvari
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-12-18       Impact factor: 4.733

Review 8.  Secret talk between adipose tissue and central nervous system via secreted factors-an emerging frontier in the neurodegenerative research.

Authors:  Avinash Parimisetty; Anne-Claire Dorsemans; Rana Awada; Palaniyandi Ravanan; Nicolas Diotel; Christian Lefebvre d'Hellencourt
Journal:  J Neuroinflammation       Date:  2016-03-24       Impact factor: 8.322

9.  The presence of cerebral and/or systemic endothelial dysfunction in patients with leukoaraiosis--a case control pilot study.

Authors:  Matija Zupan; Mišo Šabović; Marjan Zaletel; Katarina Šurlan Popovič; Bojana Žvan
Journal:  BMC Neurol       Date:  2015-09-02       Impact factor: 2.474

10.  Combined Intraperitoneal and Intrathecal Etanercept Reduce Increased Brain Tumor Necrosis Factor-Alpha and Asymmetric Dimethylarginine Levels and Rescues Spatial Deficits in Young Rats after Bile Duct Ligation.

Authors:  Jiunn-Ming Sheen; Yu-Chieh Chen; Mei-Hsin Hsu; You-Lin Tain; Hong-Ren Yu; Li-Tung Huang
Journal:  Front Cell Neurosci       Date:  2016-06-23       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.